Braden M Leonard - 30 Jul 2024 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role: 10%+ Owner
Signature: Braden Michael Leonard
Issuer symbol: ADVM
Transactions as of: 30 Jul 2024
Net transactions value: +$613,470
Form type: 4
Filing time: 31 Jul 2024, 16:19:29 UTC
Previous filing: 18 Jul 2024
Next filing: 05 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADVM	Common Stock	Purchase	$613,470	+85,800	+3.9%	$7.15	2,268,064	30 Jul 2024	Holding of BML Investment Partners, L.P.	F1
holding	ADVM	Common Stock						104,800	30 Jul 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Content

BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.